Substance evaluation - CoRAP

Substance evaluation - CoRAP

Substance evaluation - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 12 August 2022. Database contains 386 unique substances/entries.
Filter the list
Initial grounds for concern:

The List does not contain any Substances.
 
204-278-6
118-79-6
2012
Norway
CMR
Suspected PBT/vPvB
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
247-979-2
26761-45-5
2015
Denmark
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-279-1
118-82-1
2014
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Follow-up
Details
201-236-9
79-94-7
2015
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
203-872-2
111-46-6
2015
Hungary
Suspected CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-312-7
105-59-9
2013
United Kingdom
Suspected CMR
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
203-868-0
111-42-2
2012
Germany
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
216-823-5
1675-54-3
2015
Denmark
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-049-8
102-71-6
2014
United Kingdom
Suspected CMR
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-707-1
98-85-1
2019
Italy
Suspected Carcinogenic
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Information requested
Details
701-029-8
-
Estonia
CMR
Sensitiser
Consumer use
Wide dispersive use
Withdrawn
Details
274-581-6
70356-09-1
2015
Germany
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
222-429-4
3468-63-1
2019
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Wide dispersive use
Concluded
Details
273-227-8
68953-84-4
2013
Germany
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
211-463-5
646-06-0
2016
Germany
Suspected Mutagenic
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
203-308-5
105-55-5
2019
Poland
Suspected Carcinogenic
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
219-514-3
2451-62-9
2015
Poland
CMR
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
203-812-5
110-88-3
2013
Poland
Suspected CMR
Suspected PBT/vPvB
Suspected Sensitiser
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-425-9
95-50-1
2013
Hungary
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
206-022-9
288-88-0
2015
Belgium
Suspected CMR
Other hazard based concern
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
241-867-7
17928-28-8
Norway
Suspected PBT/vPvB
Wide dispersive use
Withdrawn
Details
203-820-9
110-97-4
2013
Czech Republic
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
284-366-9
84852-53-9
2012
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
247-156-8
25640-78-2
Germany
Suspected PBT/vPvB
Wide dispersive use
Withdrawn
Details
242-060-2
18172-67-3
2014
Greece
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
225-716-2
5026-74-4
Denmark
Suspected Mutagenic
Suspected Sensitiser
Consumer use
Exposure of workers
Withdrawn
Details
200-838-9
75-09-2
2016
Italy
Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
High (aggregated) tonnage
Concluded
Details
215-160-9
1308-38-9
2019
France
Suspected Reprotoxic
Suspected Sensitiser
High (aggregated) tonnage
Concluded
Details
204-633-5
123-51-3
Poland
Suspected Carcinogenic
Suspected Reprotoxic
Suspected Sensitiser
Consumer use
Exposure of workers
Withdrawn
Details
622-542-2
3891-98-3
Austria
Suspected Mutagenic
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Withdrawn
Details
204-077-3
115-27-5
2013
France
CMR
Suspected PBT/vPvB
Suspected Sensitiser
Exposure of environment
Exposure of workers
Concluded
Details
204-857-3
127-68-4
2023
Ireland
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Not started
Details
905-459-9
-
2023
France
Suspected Reprotoxic
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Not started
Details
231-760-3
7722-64-7
2017
France
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Concluded
Details
211-745-8
693-21-0
2016
Italy
Suspected Carcinogenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
High RCR
Concluded
Details
203-475-4
107-25-5
2018
Latvia
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Exposure of workers
Other exposure/risk based concern
Concluded
Details
203-584-7
108-45-2
2018
Latvia
Suspected Reprotoxic
Sensitiser
Exposure of workers
High (aggregated) tonnage
Concluded
Details
229-912-9
6834-92-0
2015
Latvia
Suspected Reprotoxic
Consumer use
High (aggregated) tonnage
High RCR
Concluded
Details
234-126-4
10544-72-6
Latvia
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High RCR
Withdrawn
Details
270-877-4
68479-98-1
2016
Denmark
Suspected Mutagenic
Suspected Reprotoxic
Ongoing
Details
237-695-7
13927-71-4
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of workers
Suspended
Details
233-047-2
10025-91-9
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Concluded
Details
931-292-6
308062-28-4
Ireland
Suspected Reprotoxic
Other hazard based concern
Withdrawn
Details
204-327-1
119-47-1
2016
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Concluded
Details
941-303-6
1689576-55-3
2024
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Not started
Details
201-240-0
79-97-0
2021
Germany
Suspected Reprotoxic
Potential endocrine disruptor
Ongoing
Details
201-052-9
77-73-6
2016
France
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
High RCR
Concluded
Details
432-520-2
232938-43-1
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Withdrawn
Details
242-016-2
18127-01-0
Sweden
Suspected Reprotoxic
Withdrawn
Details
221-975-0
3302-10-1
Spain
Suspected Reprotoxic
Exposure of workers
Withdrawn
Details
249-820-2
29736-75-2
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Other hazard based concern
Exposure of workers
Information requested
Details
203-614-9
108-77-0
2017
Poland
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Concluded
Details
627-872-0
1514-82-5
2019
Spain
Suspected Reprotoxic
Potential endocrine disruptor
Concluded
Details
220-562-2
2814-77-9
2019
Germany
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
219-372-2
2425-85-6
2019
Germany
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
202-826-9
100-18-5
2023
France
Suspected Reprotoxic
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Exposure of workers
Not started
Details
202-773-1
99-62-7
2023
France
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
222-182-2
3380-34-5
2012
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Follow-up
Details
484-450-7
-
2019
Spain
Suspected PBT/vPvB
Suspended
Details
447-780-2
-
2014
Estonia
Suspected CMR
Suspected PBT/vPvB
Exposure of environment
Exposure of workers
Concluded
Details
701-385-4
-
2021
France
Suspected Mutagenic
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
931-384-6
-
2013
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Concluded
Details
ADDITIV 104
412-780-3
1380226-46-9
France
Suspected PBT/vPvB
Concluded
Details
ROBAC AS/100
403-030-6
137398-54-0
Belgium
Suspected PBT/vPvB
Concluded
Details
700-161-3
-
2013
Netherlands
Suspected PBT/vPvB
Ongoing
Details
219-006-1
2312-35-8
2019
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Concluded
Details
444-340-1
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
262-975-0
61788-44-1
2014
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Cumulative exposure
Ongoing
Details
273-066-3
68937-41-7
2020
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Information requested
Details
201-344-6
81-33-4
Belgium
Suspected PBT/vPvB
Withdrawn
Details
206-420-2
338-83-0
2020
Belgium
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
The complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isononanal. It consists predominantly of C6 olefins and paraffins and C9 alcohols and aldehydes and boiling in the range of approximately 110°C to 202°C (230°F to 396°F).
273-110-1
68938-03-4
2023
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Not started
Details
209-909-9
597-82-0
2016
Netherlands
Suspected PBT/vPvB
Information requested
Details
267-636-0
67905-17-3
2019
Belgium
Suspected PBT/vPvB
Information requested
Details
205-201-9
135-57-9
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
221-375-9
3081-14-9
2012
Belgium
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
448-020-2
-
2013
Slovakia
CMR
Suspected PBT/vPvB
High RCR
Concluded
Details
IRGANOX L 118
404-800-4
118832-72-7
2014
Germany
Suspected PBT/vPvB
Concluded
Details
931-745-8
-
2014
Sweden
Suspected PBT/vPvB
Exposure of environment
High RCR
Follow-up
Details
272-902-4
68919-76-6
Germany
Suspected PBT/vPvB
Exposure of environment
Withdrawn
Details
404-740-9
115895-09-5
2016
Slovenia
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
248-948-6
28299-41-4
2014
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details
200-901-0
75-78-5
2014
Czech Republic
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
229-782-3
6731-36-8
2014
Germany
Suspected PBT/vPvB
Information requested
Details
202-046-9
91-17-8
2012
Finland
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
609-946-4
41637-38-1
Germany
Suspected PBT/vPvB
Exposure of environment
Withdrawn
Details
700-183-3
52299-25-9
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Concluded
Details
203-372-4
106-20-7
2019
Portugal
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
202-163-5
92-52-4
2013
Portugal
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
-
2156592-70-8
2015
Netherlands
Suspected CMR
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
309-912-6
101357-15-7
2019
Germany
Suspected PBT/vPvB
Concluded
Details
700-323-3
908020-52-0
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
700-242-3
62037-80-3
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
400-370-7
63231-51-6
2021
Finland
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
CD 28-0132; IRGALUBE 232
421-820-9
192268-65-8
2023
Netherlands
Suspected PBT/vPvB
Not started
Details
WASOX-VMAC2
458-680-3
797751-44-1
2019
Spain
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
CASSIFFIX
422-040-1
426218-78-2
2016
Spain
Suspected PBT/vPvB
Exposure of environment
High RCR
Information requested
Details
251-020-3
32388-55-9
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Withdrawn
Details
202-653-9
98-29-3
2018
Poland
Suspected Mutagenic
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Exposure of environment
Exposure of workers
Concluded
Details
233-593-1
10254-57-6
2023
Germany
Suspected PBT/vPvB
Not started
Details
253-781-7
38103-06-9
2013
Germany
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
428-970-4
13595-25-0
2014
Belgium
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Concluded
Details
202-112-7
91-97-4
2013
France
Suspected CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Concluded
Details
484-410-9
-
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
226-866-1
5521-31-3
Belgium
Suspected PBT/vPvB
Withdrawn
Details
201-222-2
79-74-3
2014
Italy
Suspected PBT/vPvB
High RCR
Ongoing
Details
211-989-5
732-26-3
2017
Belgium
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
926-564-6
-
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Conclusion under preparation
Details
700-604-0
947701-81-7
Finland
Suspected PBT/vPvB
Consumer use
Withdrawn
Details
216-475-4
1594-08-7
2019
Belgium
Suspected PBT/vPvB
Ongoing
Details
627-083-1
244235-47-0
2015
Spain
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
214-946-9
1222-05-5
2022
France
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Ongoing
Details
217-496-1
1873-88-7
Norway
Suspected PBT/vPvB
Withdrawn
Details
422-270-2
-
2019
Spain
Suspected PBT/vPvB
Suspended
Details
-
37486-69-4
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
244-617-5
21850-44-2
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
306-832-3
97416-84-7
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
236-675-5
13463-67-7
2018
France
Carcinogenic
Suspected Mutagenic
Other hazard based concern
Information requested
Details
203-632-7
108-95-2
2015
Denmark
Suspected Mutagenic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
High RCR
Concluded
Details
271-846-8
68609-97-2
2023
Ireland
Suspected Mutagenic
Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Not started
Details
223-055-4
3710-84-7
2019
Sweden
Suspected Carcinogenic
Suspected Mutagenic
Information requested
Details
202-025-4
90-93-7
2021
Netherlands
Suspected Carcinogenic
Suspected Mutagenic
Ongoing
Details
253-057-0
36483-57-5
Denmark
Suspected Carcinogenic
Suspected Mutagenic
Withdrawn
Details
231-302-2
7488-55-3
2016
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
Follow-up
Details
203-570-0
108-30-5
2013
Austria
Suspected CMR
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
204-317-7
119-36-8
2015
France
Suspected CMR
Consumer use
High (aggregated) tonnage
Concluded
Details
203-492-7
107-46-0
2013
Norway
Suspected CMR
Consumer use
High (aggregated) tonnage
Information requested
Details
204-127-4
116-15-4
2015
Italy
Suspected CMR
High (aggregated) tonnage
Concluded
Details
287-401-6
85507-79-5
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
205-480-7
141-32-2
2013
Sweden
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
215-477-2
1327-41-9
2015
France
Suspected CMR
High (aggregated) tonnage
Information requested
Details
231-208-1
7446-70-0
2015
France
Suspected CMR
Exposure of workers
High (aggregated) tonnage
High RCR
Information requested
Details
219-207-4
2386-87-0
2013
Ireland
Suspected CMR
Sensitiser
Exposure of workers
High RCR
Concluded
Details
202-804-9
99-96-7
2014
Czech Republic
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Concluded
Details
201-250-5
80-09-1
2014
Belgium
Suspected CMR
Potential endocrine disruptor
High (aggregated) tonnage
Follow-up
Details
271-085-1
68515-43-5
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
271-089-3
68515-47-9
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
700-989-5
-
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
701-339-3
-
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
203-571-6
108-31-6
2013
Austria
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
629-732-4
1224966-13-5
2015
Lithuania
Sensitiser
Exposure of sensitive populations
Exposure of workers
Concluded
Details
243-001-3
19372-44-2
2015
Germany
Sensitiser
Other hazard based concern
Exposure of workers
High (aggregated) tonnage
Concluded
Details
200-237-1
55-55-0
2020
Italy
Mutagenic
Sensitiser
Other hazard based concern
Concluded
Details
232-565-6
9000-90-2
2015
United Kingdom
Sensitiser
Consumer use
Exposure of workers
Concluded
Details
220-618-6
2835-95-2
2020
Italy
Mutagenic
Sensitiser
Other hazard based concern
Information requested
Details
204-616-2
123-30-8
2020
Italy
Mutagenic
Sensitiser
Other hazard based concern
Concluded
Details
209-711-2
591-27-5
2020
Italy
Mutagenic
Sensitiser
Other hazard based concern
Information requested
Details
278-355-8
75980-60-8
Sweden
Reprotoxic
Potential endocrine disruptor
Withdrawn
Details
214-189-4
1112-39-6
Belgium
Reprotoxic
Other hazard based concern
Exposure of workers
Withdrawn
Details
203-629-0
108-91-8
2016
Belgium
Reprotoxic
Exposure of environment
High (aggregated) tonnage
Concluded
Details
203-253-7
104-93-8
2021
Ireland
Reprotoxic
Ongoing
Details
200-657-5
67-51-6
Spain
Reprotoxic
High RCR
Withdrawn
Details
205-288-3
137-30-4
2012
Denmark
Potential endocrine disruptor
High RCR
Information requested
Details
237-159-2
13674-87-8
2023
Germany
Potential endocrine disruptor
Not started
Details
203-585-2
108-46-3
2019
France
Potential endocrine disruptor
High (aggregated) tonnage
Information requested
Details
701-263-0
-
2020
Denmark
Potential endocrine disruptor
Concluded
Details
310-154-3
121158-58-5
2018
Germany
Potential endocrine disruptor
Concluded
Details
1 - 2.5 moles ethoxylated
500-209-1
68412-54-4
2016
United Kingdom
Potential endocrine disruptor
Other hazard based concern
High (aggregated) tonnage
Concluded
Details
204-399-4
120-47-8
Germany
Potential endocrine disruptor
Withdrawn
Details
201-248-4
80-08-0
2016
Germany
Potential endocrine disruptor
Concluded
Details
200-817-4
74-87-3
2012
Italy
CMR
Potential endocrine disruptor
High RCR
Concluded
Details
200-843-6
75-15-0
2013
France
CMR
Potential endocrine disruptor
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Concluded
Details
204-262-9
118-58-1
Germany
Potential endocrine disruptor
Withdrawn
Details
202-394-1
95-14-7
2016
Germany
Potential endocrine disruptor
Exposure of environment
Follow-up
Details
202-679-0
98-54-4
2014
Germany
Potential endocrine disruptor
High (aggregated) tonnage
Ongoing
Details
D-8; DD-8
405-520-5
95235-30-6
2024
Belgium
Potential endocrine disruptor
Other exposure/risk based concern
Not started
Details
204-263-4
118-60-5
Germany
Potential endocrine disruptor
Withdrawn
Details
248-227-6
27107-89-7
2024
Netherlands
Potential endocrine disruptor
Not started
Details
229-962-1
6864-37-5
2015
Germany
Potential endocrine disruptor
Concluded
Details
EC No. 216-133-4 and EC No. 244-240-6
show/hide
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no: 216-133-4 | CAS no: 1506-02-1
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one EC / List no: 244-240-6 | CAS no: 21145-77-7
-
-
2020
Germany
Potential endocrine disruptor
High (aggregated) tonnage
Information requested
Details
262-872-0
61617-00-3
2018
Germany
Potential endocrine disruptor
Exposure of environment
Follow-up
Details
258-904-8
53988-10-6
2018
Germany
Potential endocrine disruptor
Exposure of environment
Follow-up
Details
701-394-3
1782069-81-1
2020
Germany
Potential endocrine disruptor
Ongoing
Details
429-320-2
24748-23-0
2019
Netherlands
PBT/vPvB
Information requested
Details
231-545-4
7631-86-9
2012
Netherlands
Other hazard based concern
Other exposure/risk based concern
Concluded
Details
201-202-3
79-39-0
2016
Sweden
Other hazard based concern
Exposure of workers
Conclusion under preparation
Details
BENZYL-2-NAPHTHYLETHER; BETA-NAPHTHYLBENZYLETHER (BON); BNE; BON; NIPAFAX BNE; SENSLON-50; ZO-1
405-490-3
613-62-7
2012
Czech Republic
Other hazard based concern
High (aggregated) tonnage
Concluded
Details
202-049-5
91-20-3
2016
United Kingdom
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Concluded
Details
210-871-0
624-92-0
2014
Germany
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
203-450-8
106-99-0
2014
Germany
CMR
Other exposure/risk based concern
Concluded
Details
231-150-7
7440-41-7
2013
Germany
Other exposure/risk based concern
Concluded
Details
218-645-3
2210-79-9
2016
Denmark
Mutagenic
Concluded
Details
203-002-1
102-06-7
2012
France
CMR
High (aggregated) tonnage
High RCR
Concluded
Details
213-668-5
999-97-3
2014
Spain
High (aggregated) tonnage
High RCR
Concluded
Details
200-849-9
75-21-8
2012
Austria
CMR
High (aggregated) tonnage
Concluded
Details
200-262-8
56-23-5
2012
France
CMR
Exposure of workers
High (aggregated) tonnage
Concluded
Details
260-828-5
57583-34-3
2015
Netherlands
CMR
High (aggregated) tonnage
Suspended
Details
432-240-0
12056-51-8
2017
France
Carcinogenic
Exposure of workers
Information requested
Details

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.